FUJIFILM Irvine Scientific, a specialist in the innovation and manufacture of cell culture solutions for the life science and medical markets, has announced it entered into an agreement to sell its Medical Media Business Unit (MBU) to Astorg.
Anne Dhulesia, partner, Sean Dyson, partner, and Guy Stephens, manager, L.E.K. Consulting, discuss how oncology is the single largest therapeutic area for pharmaceutical sales worldwide.
American Plant Maintenance (APM Steam), a provider of steam systems maintenance services, highlights its heat exchanger assessment and testing service, which ensures a comprehensive examination of heat exchangers.
Kindeva Drug Delivery’s global health security division, Meridian Medical Technologies secured a contract valued at up to $129 million to supply DuoDote, a chemical nerve agent antidote autoinjector, to the Strategic National Stockpile (SNS).
Vetter, a globally operating Contract Development and Manufacturing Organisation (CDMO), has announced the development and upcoming launch of the new version of its proprietary V-OVS syringe closure system.
It’s that time of year again when we take stock of the advances the biopharma industry has made and look ahead to the evolving client requirements that will shape 2025 and beyond. Subodh Deshmukh, CEO of Aragen Bioscience discusses.
Enhanc3D Genomics, an innovator in 3D genomics technology, has announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug discovery.
Brown Gibbons Lang & Company (BGL) has announced the sale of United States Drug Testing Laboratories to Northlane Capital Partners (NCP), a private equity firm specialising in healthcare and business services.
